CEO of Cystic Fibrosis Ireland Phillip Watt questions if a drug for 35 children will be fairly assessed by the NCPE

<span class="TextRun SCXW244660495 BCX0">Cystic Fibrosis Ireland questions whether a CF drug for 35 children will be fairly assessed by the National Centre for Pharmaco-Economics (NCPE) following recent newspaper comments and Phillip Watt, CEO of Cystic Fibrosis Ireland reacts</span><span class="EOP SCXW244660495 BCX0">&nbsp;</span>